APA (7th ed.) Citation

Jorgenson, M. R., Descourouez, J. L., Saddler, C. M., Smith, J. A., Odorico, J. S., Rice, J. P., & Mandelbrot, D. A. (2023). Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reduction. Clinical Transplantation, 37(12), 1. https://doi.org/10.1111/ctr.15142

Chicago Style (17th ed.) Citation

Jorgenson, Margaret R., Jillian L. Descourouez, Christopher M. Saddler, Jeannina A. Smith, Jon S. Odorico, John P. Rice, and Didier A. Mandelbrot. "Real World Experience with Conversion from Valganciclovir to Letermovir for Cytomegalovirus Prophylaxis: Letermovir Reverses Leukopenia and Avoids Mycophenolate Dose Reduction." Clinical Transplantation 37, no. 12 (2023): 1. https://doi.org/10.1111/ctr.15142.

MLA (9th ed.) Citation

Jorgenson, Margaret R., et al. "Real World Experience with Conversion from Valganciclovir to Letermovir for Cytomegalovirus Prophylaxis: Letermovir Reverses Leukopenia and Avoids Mycophenolate Dose Reduction." Clinical Transplantation, vol. 37, no. 12, 2023, p. 1, https://doi.org/10.1111/ctr.15142.